GRAIL, Inc. (GRAL)

Health Care ยท Services-Medical Laboratories

GRAIL, Inc. (GRAL) is listed on Nasdaq, where its shares have traded since June 12, 2024. SentiSense covers GRAIL, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories. Bob Ragusa is its chief executive officer. The company reports 910 employees, and its corporate website is www.grail.com.

About GRAIL, Inc.

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.

Latest reported results

GRAIL, Inc. reported revenue of $37.5 million for Q3 FY2026, up 3.7% from the same period a year earlier.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 364 institutions reported holding GRAL, with 38.0 million shares worth $2.6 billion in aggregate. The largest reported holders were Farallon Capital Management, Baker Bros. Advisors and BlackRock. Of the 5 largest reported holders, 4 added shares and 1 held its position unchanged during the quarter.

More on GRAL

  • GRAL sentiment: whether news and social coverage of GRAIL, Inc. leans bullish or bearish, and the stories driving it.
  • GRAL ownership: all 364 reporting institutions, plus insider and congressional trades.
  • GRAL financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.

SentiSense also tracks daily options readings for GRAIL, Inc.: IV rank, put/call percentile, 25-delta skew and open-interest walls.

Frequently asked questions

What does GRAIL, Inc. do?

GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection.

What sector is GRAL in?

SentiSense classifies GRAIL, Inc. in the Health Care sector, and its Standard Industrial Classification is Services-Medical Laboratories.

Where does GRAL stock trade?

GRAIL, Inc. (GRAL) is listed on Nasdaq, where its shares have traded since June 12, 2024.

Who is the CEO of GRAIL, Inc.?

Bob Ragusa is the chief executive officer of GRAIL, Inc..